Status Regarding Novo Nordisk A/S's Holding Of Its Own Shares (30 September 2017)
Published: Oct 02, 2017
Bagsværd, Denmark, 2 October 2017 - In continuation of the company's announcements dated 3 May 2017 and 9 August 2017 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 September 2017 owned 41,621,013 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 8,324,203 or 1.7% of the total share capital.
In the third quarter of 2017 a total of 14,842,082 B shares were repurchased, and 3,418 B shares were disposed to employees in connection with employee incentive programmes.
|Anne Margrethe Hauge||+45 4442 email@example.com|
|Ken Inchausti (US)||+1 609 786 firstname.lastname@example.org|
|Peter Hugreffe Ankersen||+45 3075 email@example.com|
|Hanna Ögren||+45 3079 firstname.lastname@example.org|
|Anders Mikkelsen||+45 3079 email@example.com|
|Christina Kjær||+45 3079 firstname.lastname@example.org|
|Kasper Veje (US)||+1 609 235 email@example.com|
Company announcement No 76 / 2017Attachments: